Mitochondrial Transplantation: A Novel Therapy for Liver Ischemia/Reperfusion Injury.
Summary
In mouse liver I/R, exogenous mitochondrial transplantation reduced hepatocellular injury, inflammatory cytokines, and neutrophil infiltration. Intravital imaging showed rapid Kupffer cell sequestration and lysosomal acidification of transplanted mitochondria, and CRIg on Kupffer cells was required for capture and protection.
Key Findings
- Mitochondrial transplantation reduced ALT/AST elevations and histologic injury after liver I/R.
- Pro-inflammatory cytokines (IL-6, TNFα) decreased while IL-10 increased following MTx.
- Neutrophil infiltration in liver sinusoids and lung BAL fluid was reduced, indicating local and distant anti-inflammatory effects.
- Intravital imaging showed Kupffer cells rapidly sequester and acidify transplanted mitochondria.
- Kupffer cell depletion abrogated protection, and CRIg knockout prevented mitochondrial capture and hepatoprotection.
Clinical Implications
Suggests a translatable strategy to mitigate liver I/R injury in hemorrhagic shock, major liver surgery, and transplantation, and nominates CRIg–Kupffer cell interactions as a target to enhance efficacy or select candidates.
Why It Matters
This study provides a mechanistic basis for mitochondrial transplantation as an organ-protective therapy in perioperative liver I/R, identifying CRIg-dependent Kupffer cell capture as necessary for benefit.
Limitations
- Preclinical murine model limits direct generalizability to humans
- Dose, timing, and source of mitochondria require optimization for clinical translation
Future Directions
Early-phase clinical trials to evaluate safety/feasibility of MTx in liver surgery/transplant, and strategies to augment CRIg-mediated capture or target delivery.
Study Information
- Study Type
- Case-control
- Research Domain
- Pathophysiology
- Evidence Level
- IV - Preclinical in vivo mechanistic study in mice with genetic models; hypothesis-generating.
- Study Design
- OTHER